NOW HEAR THIS, INC. – Trademark Portfolio
Entity Type: 03
NOW HEAR THIS, INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ACCUFIT and NOW HEAR THIS. The owner is based in BENICIA, CA.
537 STONE ROAD, SUITE E
BENICIA, CA 94510
Showing of trademarks Trademarks
Trademark Classifications
NOW HEAR THIS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does NOW HEAR THIS, INC. have?
NOW HEAR THIS, INC. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does NOW HEAR THIS, INC. file in?
NOW HEAR THIS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are NOW HEAR THIS, INC.'s most well-known trademarks?
NOW HEAR THIS, INC.'s registered trademark portfolio includes well-known marks such as ACCUFIT and NOW HEAR THIS. These are among 2 currently registered trademarks in the portfolio.
What is NOW HEAR THIS, INC.'s trademark registration success rate?
NOW HEAR THIS, INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.